Glucose tolerance in patients with cystic fibrosis: A five-year prospective study;Glukosetolerance hos patienter med cystisk fibrose

Ugeskrift for Laeger

Volumn 158, Issue 44, 1996, Pages 6269-6273

  Thorsteinsson, Susanne Lanng ^a   Hansen, Sygeplejerske Annelise ^b   Thorsteinsson, Birger ^b   Nerup, Jørn ^b   Koch, Christian ^b  

^a University of Copenhagen

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHILD; CYSTIC FIBROSIS; DIABETES MELLITUS; FOLLOW UP; GLUCOSE TOLERANCE TEST; HUMAN; PATHOPHYSIOLOGY; PREVALENCE; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; DIABETES MELLITUS; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; PREVALENCE; PROSPECTIVE STUDIES;

EID: 0030604969     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu S-C et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988; 112: 373-7.
2. Reisman J, Corey M, Canny G, Levison H. Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics 1990; 150: 374-7.
3. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122: 1-9.
4. Nir M, Lanng S, Koch C. Long-term survival and nutritional data in Danish Centre-treated cystic fibrosis patients. Thorax, (i trykken).
5. Handwerger S, Roth J, Gorden P, Di Sant'Agnese P, Carpenter DF, Peter G. Glucose intolerance in cystic fibrosis. N Engl J Med 1969; 281: 451-61.
6. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiøtz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis pa-tients: prevalence and late diabetic complications. Acta Pædiatr 1994; 83: 72-7.
7. WHO Study Group. Diabetes mellitus. WHO Tech Rep Ser 1985; 727:1-113.
8. Svendsen PAa, Lauritzen T, Søegaard U, Nerup J. Glycosylated haemoglobin and steady state mean blood glucose concentration in type 1 (insulin-dependent) diabetes. Diabetologia 1982; 23: 403-5.
9. Høiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Pathol Microbiol Scand. C Immunol 1977; 85 (suppl 262): 3-96.
10. Schwarlz M, Johansen HK, Koch C, Brandt NJ. Frequency of the δF508 mutation on cystic fibrosis chromosomes in Denmark. Hum Genet 1990; 85: 427-8.
11. Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. Philadelphia: WB Saunders, 1971: 88-107 og 178-82.
12. Arrigo T, Cucinotta D, Conti Nibali S, Di Cesare E, Di Benedetto A, Magazzù G et al. Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two-year follow-up. Acta Pædiatr 1993; 82: 249-53.
13. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992; 151: 684-7.
14. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections- Acta Pædiatr 1994; 83: 849-53.
15. Yudkin JS, Alberti KGMM, McLarty DG, Swai ABM. Impaired glucose tolerance. Is it a risk factor for diabetes or a diagnostic ragbag? BMJ 1990; 301: 397-402.
16. Lanng S, Thorsteinsson B, Røder ME, Ørskov C, Holst JJ, Nerup J et al. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol 1993; 128: 207-14.
17. Lanng S, Schwarte M, Thorsteinsson B, Koch C. Endocrine and exocrine pancreatic function and the δF508 mutation in cystic fibrosis. Clin Genet 1991; 40: 345-8.
18. Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP. Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991; 118: 715-23.
19. Lanng S, Thorsteinsson B, Pocoit F, Marshall MO, Madsen HO, Schwarte M et al. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Pædiatr 1993; 82: 150-4.
20. Trezise AEO, Buchwald M. In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature 1991; 353: 434-7.